[{"address1": "P.O. Box 65", "city": "Monrovia", "state": "MD", "zip": "21770", "country": "United States", "phone": "240 243 1201", "website": "https://www.glycomimetics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "GlycoMimetics, Inc. engages in the discovery and development of therapies for cancers and inflammatory diseases in the United States. The company was founded in 2003 and is based in Monrovia, Maryland.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Ms. Stephanie R. Irish CPA", "age": 53, "title": "Vice President of Accounting", "yearBorn": 1971, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christian B. Dinneen-Long", "title": "General Counsel & Company Secretary", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bruce  Johnson", "age": 56, "title": "Senior VP & Chief Commercial Officer", "yearBorn": 1968, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Chinmaya  Rath", "age": 47, "title": "Senior VP & Chief Business Officer", "yearBorn": 1977, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shantha  Tyavanagimatt Ph.D.", "title": "Senior Vice President of Technical Operations", "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 7, "compensationRisk": 6, "shareHolderRightsRisk": 9, "overallRisk": 7, "governanceEpochDate": 1748736000, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.166, "open": 0.17, "dayLow": 0.153, "dayHigh": 0.17, "regularMarketPreviousClose": 0.166, "regularMarketOpen": 0.17, "regularMarketDayLow": 0.153, "regularMarketDayHigh": 0.17, "payoutRatio": 0.0, "beta": 1.596, "forwardPE": -0.052333336, "volume": 960781, "regularMarketVolume": 960781, "averageVolume": 20621, "averageVolume10days": 96762, "averageDailyVolume10Day": 96762, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 10131540, "fiftyTwoWeekLow": 0.153, "fiftyTwoWeekHigh": 63.0, "fiftyDayAverage": 22.4946, "twoHundredDayAverage": 24.89835, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 4578659, "profitMargins": 0.0, "floatShares": 645147, "sharesOutstanding": 64532100, "sharesShort": 17100, "sharesShortPriorMonth": 18329, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.00029999999, "heldPercentInsiders": 0.026600001, "heldPercentInstitutions": 0.47765, "shortRatio": 4.93, "shortPercentOfFloat": 0.00029999999, "impliedSharesOutstanding": 64532100, "bookValue": 5.23, "priceToBook": 0.030019121, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -29486228, "trailingEps": -46.0, "forwardEps": -0.09, "lastSplitFactor": "1:100", "lastSplitDate": 1750032000, "enterpriseToEbitda": -0.193, "52WeekChange": -0.46214455, "SandP52WeekChange": 0.1116153, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "GLYC", "underlyingSymbol": "GLYC", "shortName": "GlycoMimetics, Inc.", "longName": "GlycoMimetics, Inc.", "firstTradeDateEpochUtc": 1389364200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "efe04473-e4ee-3464-8e89-48cc4b8490b8", "messageBoardId": "finmb_5703481", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.157, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "totalCash": 5614186, "totalCashPerShare": 8.7, "ebitda": -23763576, "totalDebt": 0, "quickRatio": 2.145, "currentRatio": 2.29, "returnOnAssets": -0.73987997, "returnOnEquity": -1.82657, "freeCashflow": -11340796, "operatingCashflow": -25695240, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-07-12"}]